treatment for infertility
Scope
Date
~
-
Bio & Pharma
Raphas microneedle passes US FDA's cGMP inspection
South Korea's microneedle maker Raphas Co. announced on Wednesday that it has passed the Current Good Manufacturing Practice (cGMP) inspection by ...
Jul 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong's Nabota exceeds 600,000 customers in US
South Korea's Daewoong Pharmaceutical said on Thursday that its local loyalty program for Nabota (American name: Jeuveau) in the US, a botulinum tox...
Jul 13, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N releases new drug for GERD in Indonesia
South Korean bio-health company HK inno.N Corporation's new drug for gastroesophageal reflux disease (GERD) K-CAB has been officially launched in In...
Jul 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in US for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...
Jun 30, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Chemicals, AZ mark first commercial production of diabetes drugs
South Korea's SK Chemicals has joined forces with global pharmaceutical firm AstraZeneca to initiate commercial production of a chemical drug for di...
Jun 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Daehwa Pharm applies for approval of anti-dementia patch in China
South Korea's Daehwa Pharm Co. is speeding up its advance into the Chinese market for anti-dementia medicine, applying for sales approval of its pat...
Jun 16, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm’s Cenobamate gets nod in Canada, to boost US sales
South Korea’s SK Biopharmaceuticals Co. has obtained the sales approval for its antiepileptic treatment Cenobamate in Canada, paving the way f...
Jun 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets approval to sell biosimilar in Europe
South Korea's Samsung Bioepis has received approval in Europe to sell a biosimilar of Soliris, a drug for the treatment of adult and children patien...
May 31, 2023 (Gmt+09:00)
-
Bio & Pharma
HanAll, Daewoong to develop Parkinson's treatment with US partner
South Korea's HanAll Biopharma Co. and Daewoong Pharmaceutical on Thursday said they concluded a contract with NurrOn Pharmaceuticals of the US on...
May 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Humira biosimilar CT-P17
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...
May 24, 2023 (Gmt+09:00)
-
Artificial intelligence
Neurophet strives to be first mover in fight against Alzheimer’s
Neurophet Inc., a South Korean startup developing artificial intelligence-powered medical solutions for brain diseases, is striving to make a breakt...
May 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for Phase 3 clinical trials in Europe for biosimilar
South Korea’s Celltrion Inc. is speeding up global clinical trials of its biosimilar of the multiple sclerosis (MS) treatment Ocrevus (active ...
May 03, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Kainos Medicine exports AIDS treatment technology to China
South Korean new drug developer Kainos Medicine Inc. announced on Friday that it had signed a technology transfer agreement with Chinese pharmaceuti...
Apr 21, 2023 (Gmt+09:00)
-
Korean startups
Asleep dreams big to help sleepless people worldwide find right treatment
Armed with artificial intelligence and big data technologies, Asleep hopes to find the best treatment for sleep-deprived people around the world wit...
Apr 21, 2023 (Gmt+09:00)
-
Bio & Pharma
AbClon shows promising results in clinical tests of leukemia treatment
South Korean companies are standing out in the global competition to develop chimeric antigen receptor T-cell (CAR-T) treatments, dubbed "dream" a...
Apr 19, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB starts Phase 3 clinical trials for ophthalmic disease treatment in US
South Korea's pharmaceutical company HLB Therapeutics Co. announced on Thursday that it has started patient administration of "RGN-259," a treatment...
Apr 13, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma receives 1st overseas patent for its hair loss treatment
JW Pharmaceutical, a drug company based in South Korea, has received its first patent for a hair loss treatment that is currently in development. Th...
Mar 27, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's microneedle maker Raphas to enter US market
South Korea's microneedle maker Raphas Co. is expediting its entry into the American pharmaceutical market after entering the country's cosmetics se...
Mar 27, 2023 (Gmt+09:00)
-
Bio & Pharma
PharmaResearch pays employees $7,706 bonus for having 3rd child
With South Korea setting new lows in birth rate every year, PharmaResearch on Wednesday said it will adopt an unprecedented system of childbirth and...
Mar 23, 2023 (Gmt+09:00)
-
Waste management
Toray Advanced Materials acquires S.Korea's water treatment company
Toray Advanced Materials Korea Inc. announced on Monday the acquisition of Hanmee Entec Co., Ltd., the industry's longest-running water treatment fa...
Mar 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Bio's pancreatic cancer treatment gets US FDA fast-track designation
Prestige Biopharma, a biopharmaceutical company in South Korea, announced on Thursday that their pancreatic cancer antibody drug, PBP1510 (Ulenistam...
Mar 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong wins approval for GERD treatment Fexuclu in Chile
South Korean pharmaceutical company Daewoong Pharmaceutical announced on Tuesday that it has received marketing authorization from Chile's National ...
Mar 14, 2023 (Gmt+09:00)
-
Bio & Pharma
OliX's hair loss treatment candidate approved for clinical trial in Australia
South Korea's OliX Pharmaceuticals has received approval from Australia's Human Research Ethics Committees (HREC) to plan a phase 1 clinical trial o...
Mar 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis launches ARMD biosimilar drug in Germany, Canada
Samsung Bioepis Co., a South Korean biosimilar firm, announced on Sunday that it has recently launched a new biosimilar drug called SB11 for the tre...
Mar 06, 2023 (Gmt+09:00)
-
Bio & Pharma
AIMMED’s Somzz ushers in digital therapeutic device market in Korea
South Korea’s health and drug safety authority has cleared Somzz to treat patients with sleep disorders, a dynamic move that is expected to vi...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Vaxcell-Bio, Cellid sign MOU to build cancer immunotherapy platform
Vaxcell-Bio Therapeutics, a South Korean company specializing in anti-cancer immunotherapy, announced on Wednesday its partnership with Cellid Co. t...
Feb 15, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N's GERD drug K-CAB gets approval in Mexico
South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Plasma, Janssen Korea sign sales, distribution agreement
SK Plasma Co. Ltd., a South Korean company specializing in the production of plasma derivatives from human plasma, is expanding its product portfoli...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanall Biopharma invests in Interon Labs for brain disease treatments
South Korean pharmaceuticals firm Hanall Biopharma Co. is investing in Interon Laboratories, a US biotech firm that finds and develops treatments fo...
Feb 13, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB’s Rivoceranib, Hengrui's Camrelizumab approved as combination therapy in China
South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...
Feb 09, 2023 (Gmt+09:00)
Latest News
- 1 Hyundai, Waymo forge multi-year, strategic partnership for self-driving vehicles
- 2 AI startup MarqVision raises $16.5 mn to close Series A
- 3 Taihan Cable wins $630 mn power grid project in Singapore
- 4 Korean startup scene is gloomy, say 2 out of 5 startup CEOs
- 5 MBK ups stakes for Korea Zinc to match buyback offer